{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T20:16:23Z","timestamp":1793736983099,"version":"4.6.1"},"reference-count":153,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Trained immunity, characterized by the long-term functional reprogramming of innate immune cells through epigenetic and metabolic modifications, has emerged as a pivotal concept bridging innate and adaptive immune responses. This review explores the dual role of trained immunity as both a protective mechanism in cancer and a pathogenic driver in autoimmune diseases. We first discuss the underlying mechanisms involving histone modifications, chromatin remodeling, and metabolic pathways such as glycolysis and the mTOR\/HIF-1\u03b1 axis, alongside key regulators including NOD2 and pattern recognition receptors. The contribution of trained immunity to antitumor responses is highlighted through its ability to enhance innate cell cytotoxicity, remodel the tumor microenvironment, and synergize with immune checkpoint blockade and BCG immunotherapy. Conversely, we examine how infections, dysbiosis, and dietary factors can induce maladaptive trained immunity, leading to persistent hyperinflammatory states and exacerbation of autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus, and multiple sclerosis. Furthermore, we address therapeutic strategies to modulate trained immunity, including small molecules, \u03b2-glucan, statins, and BCG derivatives, emphasizing their potential applications in cancer immunotherapy and autoimmunity control. We also underscore the risks of unintended immune activation, such as autoimmune flare-ups during cancer treatment or compromised host defense during immunosuppression. Finally, we discuss future directions, including the development of trained immunity-based vaccines, personalized immunomodulatory approaches, and the integration of multi-omics and artificial intelligence to design patient-specific interventions. Understanding the complex interplay between trained immunity, cancer, and autoimmunity will be crucial for translating these insights into innovative therapeutic strategies.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1782830","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T06:59:48Z","timestamp":1773817188000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Trained immunity in cancer and autoimmunity: a double-edged sword in immune memory reprogramming"],"prefix":"10.3389","volume":"17","author":[{"given":"Nasrin","family":"Salari","sequence":"first","affiliation":[{"name":"Cancer Research Center, Semnan University of Medical Sciences","place":["Semnan, Iran"]},{"name":"Department of Immunology, School of Medicine, Semnan University of Medical Sciences","place":["Semnan, Iran"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrshad","family":"Shams","sequence":"additional","affiliation":[{"name":"Department of Immunology, School of Medicine, Mazandaran University of Medical Sciences","place":["Sari, Iran"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh Tavassoli","family":"Razavi","sequence":"additional","affiliation":[{"name":"Cancer Research Center, Semnan University of Medical Sciences","place":["Semnan, Iran"]},{"name":"Department of Immunology, School of Medicine, Semnan University of Medical Sciences","place":["Semnan, Iran"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esmaeil","family":"Yazdanpanah","sequence":"additional","affiliation":[{"name":"Immunology Research Center, Mashhad University of Medical Sciences","place":["Mashhad, Iran"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentyn","family":"Oksenych","sequence":"additional","affiliation":[{"name":"Oslo Bioconsulting","place":["Oslo, Norway"]},{"name":"Department of Microbiology, Danylo Halytsky Lviv National Medical University","place":["Lviv, Ukraine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dariush","family":"Haghmorad","sequence":"additional","affiliation":[{"name":"Cancer Research Center, Semnan University of Medical Sciences","place":["Semnan, Iran"]},{"name":"Department of Immunology, School of Medicine, Semnan University of Medical Sciences","place":["Semnan, Iran"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1152\/advan.00058.2013","article-title":"Pattern recognition receptors in innate immunity, host defense, and immunopathology","volume":"37","author":"Suresh","year":"2013","journal-title":"Adv Physiol Educ"},{"key":"B2","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1034\/j.1600-065X.2000.917309.x","article-title":"Innate immune recognition: mechanisms and pathways","volume":"173","author":"Medzhitov","year":"2000","journal-title":"Immunol Rev"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.micinf.2007.09.002","article-title":"Macrophage receptors implicated in the \"adaptive\" form of innate immunity","volume":"9","author":"Bowdish","year":"2007","journal-title":"Microbes Infect"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2011.04.006","article-title":"Trained immunity: a memory for innate host defense","volume":"9","author":"Netea","year":"2011","journal-title":"Cell Host Microbe"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2005.02.001","article-title":"Specific memory within innate immune systems","volume":"26","author":"Kurtz","year":"2005","journal-title":"Trends Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coi.2014.02.006","article-title":"Innate immune memory: towards a better understanding of host defense mechanisms","volume":"29","author":"Quintin","year":"2014","journal-title":"Curr Opin Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms221910684","article-title":"Trained immunity as an adaptive branch of innate immunity","volume":"22","author":"Vetvicka","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2017.7310","article-title":"Epigenetics and trained immunity","volume":"29","author":"van der Heijden","year":"2018","journal-title":"Antioxidants Redox Signaling"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41590-020-00845-6","article-title":"Trained immunity, tolerance, priming and differentiation: distinct immunological processes","volume":"22","author":"Divangahi","year":"2021","journal-title":"Nat Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2007.08.122","article-title":"History of bacillus Calmette-Guerin and bladder cancer: an immunotherapy success story","volume":"179","author":"Herr","year":"2008","journal-title":"J Urol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/S1438-4221(00)80083-1","article-title":"Comparative genomics of the mycobacteria","volume":"290","author":"Brosch","year":"2000","journal-title":"Int J Med Microbiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.smim.2018.06.002","article-title":"Non-specific effects of vaccines: Current evidence and potential implications","volume":"39","author":"de Bree","year":"2018","journal-title":"Semin Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ144","article-title":"Nonspecific (Heterologous) protection of neonatal BCG vaccination against hospitalization due to respiratory infection and sepsis","volume":"60","author":"de Castro","year":"2015","journal-title":"Clin Infect Dis"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2004.09.006","article-title":"Acute lower respiratory tract infections and respiratory syncytial virus in infants in Guinea-Bissau: a beneficial effect of BCG vaccination for girls community based case-control study","volume":"23","author":"Stensballe","year":"2005","journal-title":"Vaccine"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1215761109","article-title":"Saving lives by training innate immunity with bacille Calmette-Guerin vaccine","volume":"109","author":"Aaby","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyh392","article-title":"BCG vaccination scar associated with better childhood survival in Guinea-Bissau","volume":"34","author":"Roth","year":"2005","journal-title":"Int J Epidemiol"},{"key":"B17","doi-asserted-by":"crossref","DOI":"10.1097\/INF.0b013e3182458289","article-title":"Small randomized trial among low-birth-weight children receiving bacillus Calmette-Gu\u00e9rin vaccination at first health center contact","volume":"31","author":"Biering-S\u00f8rensen","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir240","article-title":"Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period","volume":"204","author":"Aaby","year":"2011","journal-title":"J Infect Dis"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041756","article-title":"Proof-of-concept, randomized, controlled clinical trial of Bacillus-Calmette-Guerin for treatment of long-term type 1 diabetes","volume":"7","author":"Faustman","year":"2012","journal-title":"PloS One"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-019-0183-3","article-title":"Epidemiology and treatment of multiple sclerosis in elderly populations","volume":"15","author":"Vaughn","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.53.7.1588","article-title":"Use of Bacille Calmette-Gu\u00e8rin (BCG) in multiple sclerosis","volume":"53","author":"Ristori","year":"1999","journal-title":"Neurology"},{"key":"B22","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-3083.1992.tb03132.x","article-title":"The role of BCG\/PPD-activated macrophages in resistance against systemic candidiasis in mice","volume":"36","author":"van 't Wout","year":"1992","journal-title":"Scand J Immunol"},{"key":"B23","article-title":"Effect of Bacillus Callmette Guerin (BCG) on the receptivity of nude mice to Schistosoma mansoni","volume":"172","author":"Tribouley","year":"1978","journal-title":"C R Seances Soc Biol Fil"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2013.04.004","article-title":"A small jab - a big effect: nonspecific immunomodulation by vaccines","volume":"34","author":"Benn","year":"2013","journal-title":"Trends Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1202870109","article-title":"Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes","volume":"109","author":"Kleinnijenhuis","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu508","article-title":"Heterologous immunological effects of early BCG vaccination in low-birth-weight infants in Guinea-Bissau: a randomized-controlled trial","volume":"211","author":"Jensen","year":"2015","journal-title":"J Infect Dis"},{"key":"B27","doi-asserted-by":"publisher","first-page":"6588","DOI":"10.1038\/ncomms7588","article-title":"Trained immunity in newborn infants of HBV-infected mothers","volume":"6","author":"Hong","year":"2015","journal-title":"Nat Commun"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.08.103","article-title":"Risk of lymphoma and leukaemia after bacille Calmette-Gu\u00e9rin and smallpox vaccination: a Danish case-cohort study","volume":"27","author":"Villumsen","year":"2009","journal-title":"Vaccine"},{"key":"B29","doi-asserted-by":"crossref","DOI":"10.1586\/era.11.163","article-title":"Role of bacillus Calmette-Gu\u00e9rin in the treatment of advanced melanoma","volume":"11","author":"Stewart","year":"2011","journal-title":"Expert Rev Anticancer Ther"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1177\/014107680309600806","article-title":"Vaccination strategies to reduce the risk of leukaemia and melanoma","volume":"96","author":"Grange","year":"2003","journal-title":"J R Soc Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/nrurol.2014.15","article-title":"The mechanism of action of BCG therapy for bladder cancer--a current perspective","volume":"11","author":"Redelman-Sidi","year":"2014","journal-title":"Nat Rev Urol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004485","article-title":"Autophagy controls BCG-induced trained immunity and the response to intravesical BCG therapy for bladder cancer","volume":"10","author":"Buffen","year":"2014","journal-title":"PloS Pathog"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2014.10.005","article-title":"BCG-induced trained immunity in NK cells: Role for non-specific protection to infection","volume":"155","author":"Kleinnijenhuis","year":"2014","journal-title":"Clin Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.5RI0217-064RR","article-title":"Hypothesis: stimulation of trained immunity as adjunctive immunotherapy in cancer","volume":"102","author":"Netea","year":"2017","journal-title":"J Leukoc Biol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1126\/science.1250684","article-title":"mTOR- and HIF-1\u03b1-mediated aerobic glycolysis as metabolic basis for trained immunity","volume":"345","author":"Cheng","year":"2014","journal-title":"Science"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00394","article-title":"Mevalonate metabolism in cancer stemness and trained immunity","volume":"8","author":"Gruenbacher","year":"2018","journal-title":"Front Oncol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1669054","article-title":"DAMP-driven trained immunity: metabolic and epigenetic reprogramming in critical illness and chronic inflammation","volume":"16","author":"Kim","year":"2025","journal-title":"Front Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1365127","article-title":"The causes and consequences of trained immunity in myeloid cells","volume":"15","author":"Bhargavi","year":"2024","journal-title":"Front Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25073881","article-title":"An overview of the epigenetic modifications in the brain under normal and pathological conditions","volume":"25","author":"Lossi","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1177\/17448069211056767","article-title":"Epigenetic modifications in neuropathic pain","volume":"17","author":"Luo","year":"2021","journal-title":"Mol Pain"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1411-0","article-title":"Advances in epigenetics link genetics to the environment and disease","volume":"571","author":"Cavalli","year":"2019","journal-title":"Nature"},{"key":"B42","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13148-025-01838-8","article-title":"Novel histone modifications and liver cancer: emerging frontiers in epigenetic regulation","volume":"17","author":"Wang","year":"2025","journal-title":"Clin Epigenet"},{"key":"B43","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/s41392-024-01918-w","article-title":"Crossing epigenetic frontiers: the intersection of novel histone modifications and diseases","volume":"9","author":"Yao","year":"2024","journal-title":"Signal Transduction Targeted Ther"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1186\/1756-8935-7-33","article-title":"Chromatin accessibility: a window into the genome","volume":"7","author":"Tsompana","year":"2014","journal-title":"Epigenet Chromatin"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-cancerbio-062822-120857","article-title":"Deciphering the Warburg effect: metabolic reprogramming, epigenetic remodeling, and cell dedifferentiation","volume":"8","author":"Li","year":"2024","journal-title":"Annu Rev Cancer Biol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1211221","article-title":"Interplay between metabolic reprogramming and post-translational modifications: from glycolysis to lactylation","volume":"14","author":"Wu","year":"2023","journal-title":"Front Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3390\/cells11244072","article-title":"Innate immune memory in monocytes and macrophages: the potential therapeutic strategies for atherosclerosis","volume":"11","author":"Guo","year":"2022","journal-title":"Cells"},{"key":"B48","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.immuni.2020.10.011","article-title":"The intersection of epigenetics and metabolism in trained immunity","volume":"54","author":"Fanucchi","year":"2021","journal-title":"Immunity"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.122890","article-title":"HIF-1 mediated metabolic reprogramming in cancer: Mechanisms and therapeutic implications","volume":"352","author":"Taneja","year":"2024","journal-title":"Life Sci"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15082195","article-title":"Regulation of autophagy via carbohydrate and lipid metabolism in cancer","volume":"15","author":"Alizadeh","year":"2023","journal-title":"Cancers"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3390\/genes14101953","article-title":"Molecular mechanisms underpinning immunometabolic reprogramming: How the wind changes during cancer progression","volume":"14","author":"Flati","year":"2023","journal-title":"Genes"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1181823","article-title":"NOD2 in monocytes negatively regulates macrophage development through TNFalpha","volume":"14","author":"Chauvin","year":"2023","journal-title":"Front Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1664444","article-title":"Immunomodulation by bacterial products promotes innate signatures favorable to macrophage responses in tuberculosis infection","volume":"16","author":"Romero-Rodr\u00edguez","year":"2025","journal-title":"Front Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1461455","article-title":"Metabolic pathways fueling the suppressive activity of myeloid-derived suppressor cells","volume":"15","author":"Goldmann","year":"2024","journal-title":"Front Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1323333","article-title":"Potent induction of trained immunity by Saccharomyces cerevisiae \u03b2-glucans","volume":"15","author":"Vuscan","year":"2024","journal-title":"Front Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02806","article-title":"BCG-induced cross-protection and development of trained immunity: Implication for vaccine design","volume":"10","author":"Covi\u00e1n","year":"2019","journal-title":"Front Immunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.816956","article-title":"Humanized mouse models of systemic lupus erythematosus: Opportunities and challenges","volume":"12","author":"Chen","year":"2022","journal-title":"Front Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2102698118","article-title":"Trained innate immunity, long-lasting epigenetic modulation, and skewed myelopoiesis by heme","volume":"118","author":"Jentho","year":"2021","journal-title":"Proc Natl Acad Sci"},{"key":"B59","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.cell.2020.09.059","article-title":"Trained immunity-promoting nanobiologic therapy suppresses tumor growth and potentiates checkpoint inhibition","volume":"183","author":"Priem","year":"2020","journal-title":"Cell"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-022-01388-8","article-title":"Inducing trained immunity in pro-metastatic macrophages to control tumor metastasis","volume":"24","author":"Ding","year":"2023","journal-title":"Nat Immunol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1290833","article-title":"Helicobacter pylori induces a novel form of innate immune memory via accumulation of NF-\u043aB proteins","volume":"14","author":"Frauenlob","year":"2023","journal-title":"Front Immunol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25115856","article-title":"Trained immunity and trained tolerance: The case of Helicobacter pylori infection","volume":"25","author":"Dore","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/3928323","article-title":"Hyperlipidemia may synergize with hypomethylation in establishing trained immunity and promoting inflammation in NASH and NAFLD","volume":"2021","author":"Drummer","year":"2021","journal-title":"J Immunol Res"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102771","article-title":"Early hyperlipidemia triggers metabolomic reprogramming with increased SAH, increased acetyl-CoA-cholesterol synthesis, and decreased glycolysis","volume":"64","author":"Xu","year":"2023","journal-title":"Redox Biol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02014","article-title":"Interleukin-1 family cytokines: Keystones in liver inflammatory diseases","volume":"10","author":"Barbier","year":"2019","journal-title":"Front Immunol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22010436","article-title":"Immunity as cornerstone of non-alcoholic fatty liver disease: The contribution of oxidative stress in the disease progression","volume":"22","author":"Dallio","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2020.04.010","article-title":"Pulmonary surfactant phosphatidylcholines induce immunological adaptation of alveolar macrophages","volume":"122","author":"da Costa Loureiro","year":"2020","journal-title":"Mol Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2017.05.005","article-title":"Type I interferon in chronic virus infection and cancer","volume":"38","author":"Snell","year":"2017","journal-title":"Trends Immunol"},{"key":"B69","doi-asserted-by":"crossref","DOI":"10.3390\/cells11223698","article-title":"The role of IL-6 in cancer cell invasiveness and metastasis-overview and therapeutic opportunities","volume":"11","author":"Ra\u0161kov\u00e1","year":"2022","journal-title":"Cells"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-021-00363-z","article-title":"Interleukins in cancer: From biology to therapy","volume":"21","author":"Briukhovetska","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1988.6.9.1450","article-title":"Bacillus Calmette-Gu\u00e9rin therapy alters the progression of superficial bladder cancer","volume":"6","author":"Herr","year":"1988","journal-title":"J Clin Oncol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.6.1404","article-title":"Intravesical bacillus Calmette-Gu\u00e9rin therapy prevents tumor progression and death from superficial bladder cancer: Ten-year follow-up of a prospective randomized trial","volume":"13","author":"Herr","year":"1995","journal-title":"J Clin Oncol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)39365-5","article-title":"Effects of local bacillus Calmette-Guerin therapy in patients with bladder carcinoma on immunocompetent cells of the bladder wall","volume":"144","author":"B\u00f6hle","year":"1990","journal-title":"J Urol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)37668-1","article-title":"Intravesical Evans strain BCG therapy: Quantitative immunohistochemical analysis of the immune response within the bladder wall","volume":"147","author":"Prescott","year":"1992","journal-title":"J Urol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/BF00294021","article-title":"Leukocytes in the urine after intravesical BCG treatment for superficial bladder cancer. A flow cytofluorometric analysis","volume":"19","author":"de Boer","year":"1991","journal-title":"Urol Res"},{"key":"B76","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1046\/j.1442-2042.2002.00415.x","article-title":"Surface antigen expression on bladder tumor cells induced by bacillus Calmette-Gu\u00e9rin (BCG): A role of BCG internalization into tumor cells","volume":"9","author":"Ikeda","year":"2002","journal-title":"Int J Urol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat Med"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-020-0346-4","article-title":"Trained immunity as a molecular mechanism for BCG immunotherapy in bladder cancer","volume":"17","author":"van Puffelen","year":"2020","journal-title":"Nat Rev Urol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.cell.2017.12.031","article-title":"BCG educates hematopoietic stem cells to generate protective innate immunity against tuberculosis","volume":"172","author":"Kaufmann","year":"2018","journal-title":"Cell"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.34897","article-title":"Systemic versus localized Bacillus Calmette Gu\u00e9rin immunotherapy of bladder cancer promotes an anti-tumoral microenvironment: Novel role of trained immunity","volume":"155","author":"Atallah","year":"2024","journal-title":"Int J Cancer"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: Update on Toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat Immunol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.cell.2020.09.058","article-title":"Innate immune training of granulopoiesis promotes anti-tumor activity","volume":"183","author":"Kalafati","year":"2020","journal-title":"Cell"},{"key":"B83","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/s41467-022-28407-4","article-title":"The induction of peripheral trained immunity in the pancreas incites anti-tumor activity to control pancreatic cancer progression","volume":"13","author":"Geller","year":"2022","journal-title":"Nat Commun"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-006221","article-title":"Irreversible electroporation augments \u03b2-glucan induced trained innate immunity for the treatment of pancreatic ductal adenocarcinoma","volume":"11","author":"Woeste","year":"2023","journal-title":"J Immunother Cancer"},{"key":"B85","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1186\/s13287-021-02655-5","article-title":"Cytokine-induced memory-like natural killer cells for cancer immunotherapy","volume":"12","author":"Tarannum","year":"2021","journal-title":"Stem Cell Res Ther"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01371","article-title":"Myeloid-derived suppressor cells in tumors: From mechanisms to antigen specificity and microenvironmental regulation","volume":"11","author":"Yang","year":"2020","journal-title":"Front Immunol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-00490-y","article-title":"Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity","volume":"21","author":"Veglia","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-017-0022-x","article-title":"Myeloid-derived suppressor cells coming of age","volume":"19","author":"Veglia","year":"2018","journal-title":"Nat Immunol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1158\/0008-5472.CAN-09-2587","article-title":"Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine","volume":"70","author":"Srivastava","year":"2010","journal-title":"Cancer Res"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2016.1247135","article-title":"The expression profiles and regulation of PD-L1 in tumor-induced myeloid-derived suppressor cells","volume":"5","author":"Lu","year":"2016","journal-title":"Oncoimmunology"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-18-0507","article-title":"Hypoxia-induced VISTA promotes the suppressive function of myeloid-derived suppressor cells in the tumor microenvironment","volume":"7","author":"Deng","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1201018","article-title":"Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth","volume":"189","author":"Schlecker","year":"2012","journal-title":"J Immunol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.128664","article-title":"Heat-killed Mycobacterium tuberculosis prime-boost vaccination induces myeloid-derived suppressor cells with spleen dendritic cell-killing capability","volume":"5","author":"Ribechini","year":"2019","journal-title":"JCI Insight"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0903348","article-title":"Mycobacterium bovis bacillus Calmette-Gu\u00e9rin vaccination mobilizes innate myeloid-derived suppressor cells restraining in vivo T cell priming via IL-1R-dependent nitric oxide production","volume":"184","author":"Martino","year":"2010","journal-title":"J Immunol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1701005","article-title":"Rhesus macaque myeloid-derived suppressor cells demonstrate T cell inhibitory functions and are transiently increased after vaccination","volume":"200","author":"Lin","year":"2018","journal-title":"J Immunol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.1085339","article-title":"Trained immunity as a possible newcomer in autoinflammatory and autoimmune diseases pathophysiology","volume":"9","author":"Beignon","year":"2023","journal-title":"Front Med"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000630","article-title":"Infections as triggers of flares in systemic autoimmune diseases: Novel innate immunity mechanisms","volume":"31","author":"Torres-Aguilar","year":"2019","journal-title":"Curr Opin Rheumatol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00282","article-title":"Crosstalk between gut microbiota and innate immunity and its implication in autoimmune diseases","volume":"11","author":"Jiao","year":"2020","journal-title":"Front Immunol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13020329","article-title":"The interplay of nutrition, the gut microbiota and immunity and its contribution to human disease","volume":"13","author":"Dawson","year":"2025","journal-title":"Biomedicines"},{"key":"B100","first-page":"1","article-title":"The macrophages in rheumatic diseases","volume":"9","author":"Laria","year":"2016","journal-title":"J Inflammation Res"},{"key":"B101","article-title":"T lymphocyte apoptosis in systemic lupus erythematosus patients","volume":"16","author":"Rastin","year":"2013","journal-title":"Iran J Basic Med Sci"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2024.103335","article-title":"Trained innate immunity in response to nuclear antigens in systemic lupus erythematosus","volume":"149","author":"Yanginlar","year":"2024","journal-title":"J Autoimmun"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac640","article-title":"Rheumatoid arthritis macrophages are primed for inflammation and display bioenergetic and functional alterations","volume":"62","author":"Hanlon","year":"2023","journal-title":"Rheumatology"},{"key":"B104","article-title":"Inhibitory effect of Crocus sativus L. ethanol extract on adjuvant-induced arthritis","volume":"26","author":"Rabe","year":"2015","journal-title":"Food Agric Immunol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.766","article-title":"Berberine promotes immunological outcomes and decreases neuroinflammation in the experimental model of multiple sclerosis through the expansion of Treg and Th2 cells","volume":"11","author":"Tavaf","year":"2023","journal-title":"Immun Inflammation Dis"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01140","article-title":"The role of monocytes and macrophages in autoimmune diseases: a comprehensive review","volume":"10","author":"Ma","year":"2019","journal-title":"Front Immunol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.5001\/omj.2014.46","article-title":"Calcium intervention ameliorates experimental model of multiple sclerosis","volume":"29","author":"Haghmorad","year":"2014","journal-title":"Oman Med J"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200312","article-title":"Multiple sclerosis patient macrophages impaired metabolism leads to an altered response to activation stimuli","volume":"11","author":"Fransson","year":"2024","journal-title":"Neurology: Neuroimmunology Neuroinflamm"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.868343","article-title":"Trained immunity contribution to autoimmune and inflammatory disorders","volume":"13","author":"Funes","year":"2022","journal-title":"Front Immunol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1126\/science.1250684","article-title":"mTOR-and HIF-1\u03b1\u2013mediated aerobic glycolysis as metabolic basis for trained immunity","volume":"345","author":"Cheng","year":"2014","journal-title":"Science"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.11.025","article-title":"Metabolic induction of trained immunity through the mevalonate pathway","volume":"172","author":"Bekkering","year":"2018","journal-title":"Cell"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00298","article-title":"The potential role of trained immunity in autoimmune and autoinflammatory disorders","volume":"9","author":"Arts","year":"2018","journal-title":"Front Immunol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.09.034","article-title":"\u03b2-Glucan reverses the epigenetic state of LPS-induced immunological tolerance","volume":"167","author":"Novakovic","year":"2016","journal-title":"Cell"},{"key":"B114","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s44149-024-00138-7","article-title":"Trained immunity: a revolutionary immunotherapeutic approach","volume":"4","author":"Salauddin","year":"2024","journal-title":"Anim Dis"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.631743","article-title":"Therapies targeting trained immune cells in inflammatory and autoimmune diseases","volume":"11","author":"Municio","year":"2021","journal-title":"Front Immunol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1038\/s41385-022-00557-0","article-title":"Trained immunity in type 2 immune responses","volume":"15","author":"Hartung","year":"2022","journal-title":"Mucosal Immunol"},{"key":"B117","volume-title":"University of pennsylvania","author":"Jean","year":"2025"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.01.103","article-title":"Tumor-derived lactic acid contributes to the paucity of intratumoral ILC2s","volume":"30","author":"Wagner","year":"2020","journal-title":"Cell Rep"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1236301","article-title":"Innate lymphoid cells and tumor-derived lactic acid: novel contenders in an enduring game","volume":"14","author":"Marciniak","year":"2023","journal-title":"Front Immunol"},{"key":"B120","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/imr.13230","article-title":"Engineering the IL\u20104\/IL\u201013 axis for targeted immune modulation","volume":"320","author":"Bernstein","year":"2023","journal-title":"Immunol Rev"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-102119-073855","article-title":"Trained immunity: reprogramming innate immunity in health and disease","volume":"39","author":"Bekkering","year":"2021","journal-title":"Annu Rev Immunol"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17071250","article-title":"Beyond adaptive immunity: trained innate immune responses as a novel frontier in hepatocellular carcinoma therapy","volume":"17","author":"Hsieh","year":"2025","journal-title":"Cancers"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252212223","article-title":"Metabolic reprogramming of immune cells in the tumor microenvironment","volume":"25","author":"Wang","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B124","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12974-022-02463-5","article-title":"Epigenetic regulation of innate immune memory in microglia","volume":"19","author":"Zhang","year":"2022","journal-title":"J Neuroinflamm"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1080\/14728222.2017.1336539","article-title":"Hypoxia-inducible factor-1\u03b1: a promising therapeutic target for autoimmune diseases","volume":"21","author":"Guan","year":"2017","journal-title":"Expert Opin Ther Targets"},{"key":"B126","doi-asserted-by":"publisher","first-page":"10849785251396324","DOI":"10.1177\/10849785251396324","article-title":"Advancing \u03b2-glucan-based immunomodulation and nanotherapeutic strategies for cancer biotherapy","author":"Kiran","year":"2025","journal-title":"Cancer Biother Radiopharm"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241612596","article-title":"BCG-unresponsive non-muscle-invasive bladder cancer: current treatment landscape and novel emerging molecular targets","volume":"24","author":"Claps","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.102288","article-title":"Inflammation reprogramming and immunomodulation: next-generation treatments for atherosclerosis","volume":"6","author":"Choudhury","year":"2025","journal-title":"Cell Rep Med"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.3390\/cells11142187","article-title":"Epigenetic memories in hematopoietic stem and progenitor cells","volume":"11","author":"Aoyama","year":"2022","journal-title":"Cells"},{"key":"B130","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3892\/or.2021.8225","article-title":"\u03b2-glucan vaccine adjuvant approach for cancer treatment through immune enhancement (B-VACCIEN) in specific immunocompromised populations","volume":"47","author":"Ikewaki","year":"2022","journal-title":"Oncol Rep"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2022.5999","article-title":"Effect of oral \u03b2-glucan on antibody response to ganglioside vaccine in patients with high-risk neuroblastoma: a phase 2 randomized clinical trial","volume":"9","author":"Cheung","year":"2023","journal-title":"JAMA Oncol"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00341","article-title":"Optimizing tumor microenvironment for cancer immunotherapy: \u03b2-glucan-based nanoparticles","volume":"9","author":"Zhang","year":"2018","journal-title":"Front Immunol"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2018.08.014","article-title":"Effect of statins on toll-like receptors: a new insight to pleiotropic effects","volume":"135","author":"Bahrami","year":"2018","journal-title":"Pharmacol Res"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens14020196","article-title":"Beyond tuberculosis: the surprising immunological benefits of the Bacillus Calmette\u2013Gu\u00e9rin (BCG) vaccine in infectious, auto-immune, and inflammatory diseases","volume":"14","author":"Jurczak","year":"2025","journal-title":"Pathogens"},{"key":"B135","doi-asserted-by":"publisher","first-page":"6090","DOI":"10.1038\/s41467-023-41768-8","article-title":"Intravenous administration of BCG in mice promotes natural killer and T cell-mediated antitumor immunity in the lung","volume":"14","author":"Moreo","year":"2023","journal-title":"Nat Commun"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01317","article-title":"The humoral immune response to BCG vaccination","volume":"10","author":"Tanner","year":"2019","journal-title":"Front Immunol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00212-24","article-title":"BCG therapy in bladder cancer and its tumor microenvironment interactions","volume":"38","author":"Jian","year":"2025","journal-title":"Clin Microbiol Rev"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10050827","article-title":"Recombinant BCG to enhance its immunomodulatory activities","volume":"10","author":"Kowalewicz-Kulbat","year":"2022","journal-title":"Vaccines"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2025.05.026","article-title":"A fungal-derived adjuvant amplifies the antitumoral potency of Bacillus Calmette-Gu\u00e9rin via reprogramming granulopoiesis","volume":"58","author":"Jurado","year":"2025","journal-title":"Immunity"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.123617","article-title":"Beta glucan as an immune stimulant in tumor microenvironment\u2014Insight into lessons and promises from past decade","volume":"234","author":"Mishra","year":"2023","journal-title":"Int J Biol Macromol"},{"key":"B141","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2024.09.009","article-title":"Trained immunity\u2013based vaccines for infections and allergic diseases","volume":"154","author":"Mart\u00edn-Cruz","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2268","article-title":"Metabolic reprogramming and immune regulation in viral diseases","volume":"32","author":"Ganesh","year":"2022","journal-title":"Rev Med Virol"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1038\/s44222-024-00193-2","article-title":"Engineered polysaccharides for controlling innate and adaptive immune responses","volume":"2","author":"Nam","year":"2024","journal-title":"Nat Rev Bioeng"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2022.2040238","article-title":"Prophylactic and therapeutic insights into trained immunity: a renewed concept of innate immune memory","volume":"18","author":"Bindu","year":"2022","journal-title":"Hum Vaccines Immunotherapeutics"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-1340","article-title":"Roles for innate immunity in combination immunotherapies","volume":"77","author":"Moynihan","year":"2017","journal-title":"Cancer Res"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1435306","article-title":"The role of hypoxic microenvironment in autoimmune diseases","volume":"15","author":"Gong","year":"2024","journal-title":"Front Immunol"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.774103","article-title":"mTOR-mediated regulation of immune responses in cancer and tumor microenvironment","volume":"12","author":"Mafi","year":"2022","journal-title":"Front Immunol"},{"key":"B148","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.immuni.2022.02.006","article-title":"Single-cell immunology: past, present, and future","volume":"55","author":"Ginhoux","year":"2022","journal-title":"Immunity"},{"key":"B149","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1111\/brv.13049","article-title":"Specific regulation of epigenome landscape by metabolic enzymes and metabolites","volume":"99","author":"Yu","year":"2024","journal-title":"Biol Rev"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.106359","article-title":"Integrative multi-omics approaches to explore immune cell functions: challenges and opportunities","volume":"26","author":"Wang","year":"2023","journal-title":"Iscience"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2024.2415823","article-title":"Knowledge mapping of trained immunity\/innate immune memory: insights from two decades of studies","volume":"20","author":"He","year":"2024","journal-title":"Hum Vaccines Immunotherapeutics"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-021-00690-1","article-title":"Single-cell epigenomic landscape of peripheral immune cells reveals establishment of trained immunity in individuals convalescing from COVID-19","volume":"23","author":"You","year":"2021","journal-title":"Nat Cell Biol"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1290746","article-title":"The diagnosis of tuberculous meningitis: advancements in new technologies and machine learning algorithms","volume":"14","author":"Shi","year":"2023","journal-title":"Front Microbiol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1782830\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T06:59:50Z","timestamp":1773817190000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1782830\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":153,"alternative-id":["10.3389\/fimmu.2026.1782830"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1782830","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]},"article-number":"1782830"}}